Agostinelli Andrea, Carino Davide, Borrello Bruno, Marcato Carla, Volpi Annalisa, Gherli Tiziano, Nicolini Francesco
Department of Cardiac Surgery, Parma University Hospital, Parma, Italy.
Aortic Institute at Yale-New Haven, Yale University School of Medicine, New Haven, CT, USA.
Interact Cardiovasc Thorac Surg. 2019 Jan 1;28(1):17-22. doi: 10.1093/icvts/ivy211.
Blunt thoracic aortic injury can be treated with thoracic endovascular aortic repair (TEVAR) with excellent short and mid-term outcomes. However, few data are available about the long-term results. Our goal was to report our single-centre, 20-year experience using TEVAR to treat blunt thoracic aortic injury.
We retrospectively reviewed our institutional database to identify all patients treated with TEVAR for traumatic lesions of the aortic isthmus. We identified 35 patients since 1998. Patients' charts were analysed for preoperative characteristics, intraoperative variables and short-term outcomes. Information about the long-term follow-up was collected by analysing cross-sectional images and via phone calls. Follow-up was 100% complete. Rates of survival and of freedom from aortic redo were estimated using Kaplan-Meier methods.
Twenty-nine patients were men (82%). The median age was 42 years (range 22-79 years) and the mean injury severity score was 38 (±13). The endovascular procedure was successfully carried out in all patients. The left subclavian artery was intentionally overstented in 11 patients (31%). Two patients died perioperatively (5.7%). The estimated survival was 92% and 87% at 5 and 10 years, respectively, with no aorta-related deaths. The estimated freedom from aortic redo was 96% and 91% at 5 and 10 years, respectively.
Our data corroborate the excellent results of the endovascular treatment of blunt thoracic aortic injury when follow-up is extended to 20 years. New-generation devices, which are more comfortable and have smaller diameters, may further improve the results of TEVAR in treating traumatic aortic injury. Surveillance with cross-sectional imaging remains mandatory.
钝性胸主动脉损伤可采用胸主动脉腔内修复术(TEVAR)治疗,短期和中期效果良好。然而,关于长期结果的数据较少。我们的目标是报告我们单中心20年来使用TEVAR治疗钝性胸主动脉损伤的经验。
我们回顾性分析了机构数据库,以确定所有接受TEVAR治疗主动脉峡部创伤性病变的患者。自1998年以来,我们共确定了35例患者。分析患者病历的术前特征、术中变量和短期结果。通过分析横断面图像和电话随访收集长期随访信息。随访完成率为100%。采用Kaplan-Meier方法估计生存率和免于主动脉再次手术的发生率。
29例患者为男性(82%)。中位年龄为42岁(范围22 - 79岁),平均损伤严重程度评分为38(±13)。所有患者均成功完成血管内手术。11例患者(31%)有意对左锁骨下动脉进行过度支架置入。2例患者围手术期死亡(5.7%)。5年和10年的估计生存率分别为92%和87%,无主动脉相关死亡。5年和10年免于主动脉再次手术的估计发生率分别为96%和91%。
我们的数据证实了将钝性胸主动脉损伤的血管内治疗随访延长至20年时的优异结果。新一代更舒适、直径更小的器械可能会进一步改善TEVAR治疗创伤性主动脉损伤的效果。横断面成像监测仍然是必要的。